Clinical trials: Myasthenia Gravis Crisis
Myasthenia Gravis (MG), Myasthenia Gravis, Generalized
AXIS MG Patient Registry
The goal of the AXIS Autoimmune Neurology Registry is to learn about the experiences of adults living with autoimmune neurological disorders, starting with myasthenia gravis (MG), over time.
- Conditions
- Myasthenia Gravis (MG), Myasthenia Gravis, Generalized, Myasthenia Gravis, Ocular, Myasthenia Gravis Crisis
- Trial name
- AXIS (NCT07761026)
- Where
- United States
- Volunteers
- 1,000 people
- Sponsor
- Autoimmune Neurology Alliance
Myasthenic Crisis, Myasthenia Gravis (MG)
Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria.
This study compares the clinical effectiveness of Intravenous Immunoglobulin (IVIG) versus Plasma Exchange (PLEX) in patients experiencing a myasthenic crisis.
- Trial name
- NCT07532707
- Testing
- IVIG (Intravenous Immunoglobulin), Plasma exchange (PE)
- Where
- Syria
- Volunteers
- 50 people
- Sponsor
- Damascus University
Myasthenia Gravis Crisis, Myasthenia Gravis Exacerbations
Treatment of Myasthenia Gravis Exacerbation or Crisis With Efgartigimod
This study plans to learn more about if the drug efgartigimod can be used in the hospital to treat exacerbations in participants with myasthenia gravis (MG).
- Conditions
- Myasthenia Gravis Crisis, Myasthenia Gravis Exacerbations, AChR Myasthenia Gravis
- Trial name
- NCT06860633
- Testing
- Efgartigimod
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- University of Colorado, Denver
Myasthenia Gravis Crisis
Intravenous Human IgG1 Fc Fragment (Efgartigimod) in Myasthenic Crisis
Efgartigimod in Myasthenic Crisis Background Myasthenia gravis (MG) is a prevalent autoimmune disorder affecting neuromuscular junctions, characterized by weakness in skeletal muscles.
- Trial name
- NCT06688253
- Testing
- IV efgartigimod
- Where
- Israel
- Volunteers
- 16 people
- Sponsor
- Rambam Health Care Campus
Myasthaenia Gravis, Myasthenia
Myasthenia Gravis Foundation of America Global MG Patient Registry
The goal of this observational study is to learn about the experiences of people living with Myasthenia Gravis (MG) in the United States.
- Conditions
- Myasthaenia Gravis, Myasthenia, Myasthenia Gravis Associated with Thymoma, Myasthenia Gravis Crisis
- Trial name
- MGFAPR (NCT06617741)
- Where
- United States
- Volunteers
- 3,800 people
- Sponsor
- Myasthenia Gravis Foundation of America
Myasthenia Gravis, Autoimmune Diseases of the Nervous System
Predictors and Prognostic Factors of Myasthenia Gravis Outcome
This study aims to characterize the clinical features, frequency of different subgroups of MG, and identify predictors of treatment responsiveness among different subgroups of MG.
- Conditions
- Myasthenia Gravis, Autoimmune Diseases of the Nervous System, Neuromuscular Junction Diseases, Thymoma
- Trial name
- NCT05214612
- Testing
- Drug treatment of myasthenia gravis and treatment of crisis
- Where
- Egypt
- Volunteers
- 30 people
- Sponsor
- Assiut University
Myasthenia Gravis, Myasthenic Crisis
Study of Myasthenic Crisis in China
This study is a multicenter, prospective, observational research. It will register the basic demographic information, medical history characteristics, clinical features, auxiliary examinations, treatment, outcomes of tracheal…
- Trial name
- NCT04837625
- Testing
- no interventions
- Where
- China
- Volunteers
- 300 people
- Sponsor
- Huashan Hospital
Myasthenia Gravis, Myasthenia Gravis Crisis
A Prospective Cohort Study Of Myasthenia Gravis
The average annual incidence of Myasthenia gravis is up to (8.0-20.0) / 100,000 people. Myasthenia gravis is an acquired autoimmune disease. All skeletal muscles of patients may be involved.
- Trial name
- NCT04674605
- Testing
- biomarkers
- Where
- 2 sites in China
- Volunteers
- 200 people
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
Myasthenic Crisis, Upper Respiratory Infection
Incidence and Risk of Influenza in Myasthenic Patients
Upper respiratory infection , including influenza, may exacerbate the symptoms of myasthenia gravis (MG), which is an autoimmune disease that causes muscle weakness and, in some cases, can precipitate a myasthenic crisis In the…
- Trial name
- NCT03884777
- Volunteers
- 400 people
- Sponsor
- Centre d'Investigation Clinique et Technologique 805